首页> 美国卫生研究院文献>Environmental Health Perspectives >Contribution of lead from calcium supplements to blood lead.
【2h】

Contribution of lead from calcium supplements to blood lead.

机译:钙补充剂中铅对血铅的贡献。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We conducted a case-control study to determine the contribution of lead to blood from consumption of calcium supplements approximating the recommended daily intakes over a 6-month period. Subjects were males and females ages 21 to 47 years (geometric mean 32 years) with a geometric mean blood lead concentration of 2.5 microg/dL. They were subdivided into three groups. One treatment group (n = 8) was administered a complex calcium supplement (carbonate/phosphate/citrate) and the other treatment group (n = 7) calcium carbonate. The control group (n = 6) received no supplement. The lead isotopic compositions of the supplements were completely different from those of the blood of the subjects, allowing us easily to estimate contribution from the supplements. The daily lead dose from the supplements at 100% compliance was about 3 microg Pb. Three blood samples were taken at 2-month intervals before treatment to provide background values, and three were taken during treatment. Subjects in the treatment group were thus their own controls. Lead isotopic compositions for the complex supplement showed minimal change during treatment compared with pretreatment. Lead isotopic compositions in blood for the calcium carbonate supplement showed increases of up to 0.5% in the (206)Pb/(204)Pb ratio, and for all isotope ratios there was a statistically significant difference between baseline and treatment (p < 0.005). The change from baseline to treatment for the calcium carbonate supplement differed from that for both the control group and the group administered the complex supplement. Blood lead concentrations, however, showed minimal changes. Variations in blood lead levels over time did not differ significantly between groups. Our results are consistent with earlier investigations using radioactive and stable lead tracers, which showed minimal gastrointestinal absorption of lead in the presence of calcium (+/- phosphorus) in adults. Even though there is no discernible increase in blood lead concentration during treatment, there are significant changes in the isotopic composition of lead in blood arising from the calcium carbonate supplement, indicating a limited input of lead from diet into the blood. Because calcium carbonate is overwhelmingly the most popular calcium supplement, the changes we have observed merit further investigation. In addition, this type of study, combined with a duplicate diet, needs to be repeated for children, whose fractional absorption of lead is considerably higher than that of adults.
机译:我们进行了一项病例对照研究,以确定摄入的钙补充剂对铅的血液影响,该补充量与建议的6个月内的每日摄入量近似。受试者为年龄在21至47岁(几何平均32岁)的男性和女性,血铅几何平均浓度为2.5 microg / dL。他们分为三组。一个治疗组(n = 8)被给予复合钙补充剂(碳酸盐/磷酸盐/柠檬酸盐),另一治疗组(n = 7)被给予碳酸钙。对照组(n = 6)未接受任何补充。补充剂中的铅同位素组成与受试者血液中的铅同位素组成完全不同,因此我们可以轻松估算出补充剂的贡献。补充剂在100%顺应性下的每日铅剂量约为3微克铅。在治疗前每两个月间隔采集三个血样以提供背景值,在治疗过程中采集三个。因此,治疗组中的受试者是他们自己的对照。与预处理相比,复杂补充剂中的铅同位素组成显示出最小的变化。碳酸钙补充剂的血液中铅同位素组成显示(206)Pb /(204)Pb比增加高达0.5%,并且对于所有同位素比,基线和治疗之间存在统计学上的显着差异(p <0.005) 。碳酸钙补充剂从基线到治疗的变化不同于对照组和给予复合补充剂的组。但是,血铅浓度变化很小。两组之间的血铅水平随时间的变化没有显着差异。我们的结果与早期使用放射性和稳定的铅示踪剂进行的研究一致,后者显示了成年人在钙(+/-磷)存在下胃肠道对铅的吸收最少。即使在治疗过程中血铅浓度没有明显增加,但碳酸钙补充剂会导致血液中铅的同位素组成发生重大变化,这表明饮食中铅的输入有限。由于碳酸钙绝对是最受欢迎的钙补充剂,因此我们观察到的变化值得进一步研究。此外,需要对儿童重复进行此类研究,并重复饮食,因为儿童的铅吸收率要比成年人高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号